PDA

View Full Version : ImmunoGen, Inc. Announces Start Of SAR566658 Clinical Testing

News
09-23-2010, 06:10 AM
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, announced the start of clinical testing with SAR566658...

More... (http://mnt.to/f/3Kdk)